Oral delivery of low molecular weight heparin microspheres prepared using biodegradable polymer matrix system.
- Published in:
- Journal of Microencapsulation, 2009, v. 26, n. 6, p. 493, doi. 10.1080/02652040802465719
- By:
- Publication type:
- Article
Works by Lanke, Shankar
Results: 5
1
2
Population Pharmacokinetic Analyses and Model Validation of Tolvaptan in Subjects With Autosomal Dominant Polycystic Kidney Disease.
- Published in:
- Journal of Clinical Pharmacology, 2019, v. 59, n. 5, p. 763, doi. 10.1002/jcph.1370
- By:
- Publication type:
- Article
3
AUC-Guided Vancomycin Dosing in Adolescent Patients With Suspected Sepsis.
- Published in:
- Journal of Clinical Pharmacology, 2017, v. 57, n. 1, p. 77, doi. 10.1002/jcph.782
- By:
- Publication type:
- Article
4
Designing phase I oncology dose escalation using dose–exposure–toxicity models as a complementary approach to model‐based dose–toxicity models.
- Published in:
- CPT: Pharmacometrics & Systems Pharmacology, 2022, v. 11, n. 10, p. 1371, doi. 10.1002/psp4.12851
- By:
- Publication type:
- Article
5
Population Pharmacokinetic Modeling of Adavosertib (AZD1775) in Patients with Solid Tumors.
- Published in:
- Journal of Clinical Pharmacology, 2024, v. 64, n. 11, p. 1419, doi. 10.1002/jcph.2492
- By:
- Publication type:
- Article